top of page

Jennifer "JB" Bluemling, EMBA

Co-Founder,
Chief Operating Officer

  • LinkedIn_BSP_LinkedIn_Pink

Bio

As the Chief Operating Officer at Blue Sky Pharmaceuticals, JB is dedicated to driving operational excellence and fostering a culture of innovation. Her role involves overseeing the day-to-day operations, ensuring strategic goals are met, and aligning operational strategies with the company's mission to empower global health through breakthrough therapies.

Before joining Blue Sky Pharmaceuticals, JB served as VP of Global Marketing at Overhaul, a global logistics software startup, where she led multi-channel marketing strategies, demand generation initiatives and investor relations across multiple markets including North America, South America and Europe. JB’s experience also includes significant roles at 1Path, KMS Technology, and B2B Technologies, where she developed and executed comprehensive marketing campaigns, nurtured strategic partnerships, and drove quantifiable leads through innovative marketing initiatives.

​JB's educational background hails from the University of Georgia's Terry College of Business, where she earned an Executive MBA with dual specializations in International Business and Marketing. Her graduate education advanced her expertise in global market strategies, cross-cultural leadership, and data-informed decision-making. She also holds a dual undergraduate degree from the University of Georgia, graduating with an ABJ in Advertising and a BA in English.

Blue Sky Logo Cloud_Full Color Logo Set BSP.png

Tel: +353 87 330 1590

Ardee, Co. Louth

Ireland

OUR MISSION

Founded in 2024 out of a desire to save the world’s most vulnerable from the threat of treatment-resistant infections, our mission is to develop pioneering therapies that combat the most pressing infectious disease needs as well as debilitating inflammatory diseases and cancer, ensuring safe and effective treatments are accessible worldwide to improve the lives of patients for generations to come.

  • LinkedIn_BSP_LinkedIn_Pink

© 2025 Blue Sky Pharmaceuticals LTD. 

SUBSCRIBE

Sign up to receive Blue Sky Pharma news and updates.

bottom of page